Moledina et al.12 have shown that urine TNF-α and IL-9 improve discrimination over clinician prebiopsy diagnosis of AIN and could be helpful in the setting of ICI-AKI, but these biomarkers have not been validated in the setting of ICI therapy.12 The gene discussed is IL9; the disease is acute kidney injury.